CAR T Cell Therapy for Solid Tumors

Annual Review of Medicine - Tập 68 Số 1 - Trang 139-152 - 2017
Kheng Newick1, Shaun O’Brien1, Edmund K. Moon1, Steven Μ. Albelda1
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104;

Tóm tắt

The field of cancer immunotherapy has been re-energized by the application of chimeric antigen receptor (CAR) T cell therapy in cancers. These CAR T cells are engineered to express synthetic receptors that redirect polyclonal T cells to surface antigens for subsequent tumor elimination. Many CARs are designed with elements that augment T cell persistence and activity. To date, CAR T cells have demonstrated tremendous success in eradicating hematologic malignancies (e.g., CD19 CARs in leukemias). However, this success has yet to be extrapolated to solid tumors, and the reasons for this are being actively investigated. We characterize some of the challenges that CAR T cells have to surmount in the solid tumor microenvironment and new approaches that are being considered to overcome these hurdles.

Từ khóa


Tài liệu tham khảo

10.1016/j.ccell.2015.03.001

10.1038/sj.gt.3301570

10.1016/j.blre.2015.10.003

10.1158/1078-0432.CCR-14-2675

10.1182/blood-2011-05-354449

10.1200/JCO.2014.58.0225

10.1007/s11427-016-5023-8

10.1038/nri3191

10.1056/NEJMoa0810097

10.1126/scitranslmed.aaa4963

10.1089/hum.2012.041

10.4049/jimmunol.180.7.4901

10.1158/1078-0432.CCR-10-0192

10.1158/2159-8290.CD-15-0583

10.1158/0008-5472.CAN-14-0337

10.1073/pnas.95.2.669

10.1038/mt.2011.256

10.1126/scitranslmed.3010162

10.1038/mt.2010.24

10.1158/2326-6066.CIR-13-0008

10.1038/nbt.2459

10.1158/1078-0432.CCR-13-0709

10.1158/2326-6066.CIR-13-0170

10.1007/s10875-012-9689-9

10.1038/mtna.2013.32

10.1158/2326-6066.CIR-13-0027

10.1158/0008-5472.CAN-12-3913

10.1111/imr.12125

10.1158/1078-0432.CCR-14-2085

10.1182/blood-2011-12-400044

10.1038/mt.2014.156

10.1038/sj.cgt.7701021

10.1038/mt.2015.4

10.1158/0008-5472.CAN-08-2281

10.1097/CJI.0b013e3181ee6675

10.1158/1078-0432.CCR-11-0351

10.1158/2326-6066.CIR-15-0263

10.1158/0008-5472.CAN-14-0697

10.1038/mt.2015.119

10.1038/nm.3833

10.3389/fimmu.2016.00032

10.1126/scitranslmed.aaa1260

10.1182/blood-2006-07-035972

10.4049/jimmunol.180.7.4476

10.3389/fimmu.2014.00409

10.1182/blood-2015-01-621474

10.1158/0008-5472.CAN-14-3283

10.1172/JCI69589

10.1084/jem.146.6.1719

10.1007/s00262-008-0494-5

10.4049/jimmunol.1301843

10.1016/j.cell.2008.07.001

10.1158/1078-0432.CCR-08-0356

10.1182/blood.V99.9.3179

10.1038/nri2506

10.1158/0008-5472.CAN-14-3443

10.1007/s00262-015-1692-6

10.4049/jimmunol.1103019

10.1038/nri2785

10.1182/blood-2010-03-275446

10.1038/nm.3286

10.1158/1078-0432.CCR-13-1016

10.1182/blood-2011-10-386482

10.1038/mt.2011.9

10.1182/blood-2009-09-241398

10.4049/jimmunol.172.1.104

10.1158/1078-0432.CCR-13-2627

10.1158/1078-0432.CCR-13-0458

10.1158/1078-0432.CCR-15-1070

10.1093/jnci/djv146

10.1097/CJI.0000000000000064

10.4161/onci.26492

10.1158/0008-5472.CAN-12-3874

10.1158/0008-5472.CAN-04-2006

10.1182/blood-2013-10-535245

10.1182/blood-2011-03-344275

10.1158/2326-6066.CIR-15-0054

Thông tin
Thông tin xuất bản

Annual Review of Medicine

Tập 68 Số 1

139-152

Thông tin tác giả